Microcurrent Stimulation for Dry Age-related Macular Degeneration

N/AWithdrawnNCT04511936

i-Lumen Scientific, Inc.

Overview

Evaluate the safety and efficacy of microcurrent stimulation therapy for patients with dry age-related macular degeneration.

Multi-center, double-masked, randomized trial of microcurrent stimulation for the treatment of patients affected with dry age-related macular degeneration.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Conditions

Dry Age-related Macular Degeneration

Interventions

i-Lumen AMDDEVICE

Microcurrent stimulator

i-Lumen AMD ShamDEVICE

Sham microcurrent stimulator

Eligibility

Sex: ALLMin age: 50 Years

Medical Language ↔ Plain English

Key Inclusion Criteria - Study Eye: * Dry AMD diagnosis. Key Exclusion Criteria - Study Eye: * Wet AMD

Outcomes

Primary Outcomes

Mean change from baseline in best-corrected distance visual acuity (CDVA) at one month timepoint.

Time frame: 1 Month

Secondary Outcomes

Best-corrected distance visual acuity (CDVA) response rate at 1 month visit.

Time frame: 1 Month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.